Regency Centers Corp (REG) Stock News

Rosen Law Firm is seeking lead plaintiffs for a securities class action lawsuit against PicS N.V., alleging the company made false and misleading statements in its January 2026 IPO offering documents. The lawsuit claims PicS failed to disclose deficient credit evaluation procedures, material reclassifications of credit exposures, undisclosed high Stage 3 formation rates, overstated credit models, and deteriorating customer credit quality. The lead plaintiff deadline is August 4, 2026.

Rosen Law Firm is encouraging investors who purchased securities of First Solar, Veritone, and Alibaba during specified periods to join class action lawsuits. First Solar faces allegations of overstating its capacity to manage U.S. tariff impacts and understating negative effects on 2026 fiscal year performance. The lead plaintiff deadline for First Solar is August 24, 2026.

Rosen Law Firm is alerting Sportradar Group AG investors who purchased shares between November 7, 2024 and April 21, 2026 about a July 17, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Sportradar made false statements about compliance and ethics while secretly working with black-market gambling operators and maintaining inadequate Know-Your-Customer processes.

Rosen Law Firm has filed a class action lawsuit on behalf of Genius Group Limited (GNS) investors who purchased or sold securities between April 12, 2022 and May 30, 2025. The lawsuit alleges that Citadel Securities LLC and Virtu Americas LLC engaged in illegal 'spoofing' practices—submitting and cancelling orders without intent to execute them—to manipulate stock prices and mislead market participants about supply, demand, and volatility. The deadline to serve as lead plaintiff is August 28, 2026.

Rosen Law Firm is encouraging investors who purchased Badger Meter common stock between April 18, 2024 and April 16, 2026 to join a securities class action lawsuit. The lawsuit alleges that Badger Meter made materially false and misleading statements about its financial results and growth prospects by concealing a practice of pulling forward customer orders to recognize revenue early, which masked weakening demand and deteriorating order trends. The lead plaintiff deadline is August 3, 2026.

THEA, a predictive behavioral AI network focused on risk markets, announced $8 million in financing led by Maven11 Capital. However, the article begins with a retraction notice advising readers to disregard the original news release, creating significant uncertainty about the announcement's validity.

Rosen Law Firm is encouraging investors who purchased securities of Nano-X Imaging Ltd. (NNOX) between March 31, 2025 and April 17, 2026 to join a class action lawsuit. The firm alleges that Nano-X made false statements about operational efficiency and product demand, while concealing poor manufacturing alignment, increased operating expenses, and cash burn. The lead plaintiff deadline is August 11, 2026. The firm is also investigating potential securities claims for ADMA Biologics and DNOW Inc.

Rosen Law Firm is notifying investors in FS KKR Capital Corp. (FSK), ChampionX Corporation (CHX), and Lucid Group, Inc. (LCID) of upcoming lead plaintiff deadlines in securities class action lawsuits. FSK investors have until July 6, 2026, while CHX and LCID have July 14 and unspecified deadlines respectively. The lawsuits allege false statements regarding portfolio valuations, operational effectiveness, and business prospects.

Rosen Law Firm announces securities class action lawsuits against AeroVironment, Futu Holdings Limited, and TruBridge, Inc. AeroVironment is accused of making false statements about competition risks related to U.S. Space Force contracts. Investors with losses exceeding $100,000 are encouraged to join the class actions before the July 27, 2026 lead plaintiff deadline.

Rosen Law Firm is notifying investors about ongoing securities class action lawsuits against Roblox Corporation and FS KKR Capital Corp. The Roblox lawsuit alleges the company made materially false statements about its organic growth potential, concealing that age verification rollout would cause significant growth slowdown. Investors who purchased shares during specified periods are encouraged to join the class action before respective deadlines.

Rosen Law Firm is encouraging investors with losses exceeding $100,000 in Regencell Bioscience Holdings Limited, FS KKR Capital Corp., and Microsoft to join securities class action lawsuits. The firm has set a June 23, 2026 deadline for lead plaintiff claims. The lawsuits allege that defendants made false or misleading statements regarding market manipulation vulnerabilities and regulatory risks.

Rosen Law Firm is reminding investors in Regencell Bioscience Holdings Limited (RGC) and AeroVironment, Inc. (AVAV) of upcoming lead plaintiff deadlines in securities class action lawsuits. The lawsuits allege that defendants made false or misleading statements regarding market manipulation vulnerabilities, regulatory risks, and financial exposure during their respective class periods.

Fluency has issued a retraction notice advising that a previous news release from June 11, 2026, regarding CVS using Fluency to close enterprise AI deployment gaps should be disregarded by journalists and readers.

Thor Industries' Board of Directors approved a regular quarterly cash dividend of $0.52 per share, payable on July 15, 2026, to shareholders of record as of July 1, 2026. The company is the world's largest manufacturer of recreational vehicles.

Rosen Law Firm is urging investors who purchased Graphic Packaging Holding Company (GPK) securities between February 4, 2025 and February 2, 2026 to join a class action lawsuit. The lawsuit alleges that the company made false statements regarding inventory management issues, reduced demand, increased costs, and overstated its business model strength. Investors must act by the July 6, 2026 lead plaintiff deadline.

Rosen Law Firm is urging Stellantis N.V. investors who purchased stock between February 26, 2025 and February 5, 2026 to join a securities class action lawsuit before the June 8, 2026 deadline. The lawsuit alleges that Stellantis made false statements about its earnings growth potential and electrification strategy, and was not well-positioned to capitalize on EV opportunities, ultimately requiring significant charges to shift away from battery-powered electric vehicles.

Rosen Law Firm is reminding investors who purchased POET Technologies securities between April 1-27, 2026 of a June 29, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that POET Technologies made false statements regarding its tax status as a potential passive foreign investment company (PFIC), failed to disclose negative tax implications for U.S. shareholders, and that a defendant violated a non-disclosure agreement by discussing business agreements publicly.

Rosen Law Firm announces securities class action lawsuits against ImmunityBio, Inc. and other companies for allegedly making false and misleading statements. The firm is seeking lead plaintiffs with losses exceeding $100,000 before the May 26, 2026 deadline. According to the lawsuit, ImmunityBio's defendant Patrick Soon-Shiong materially overstated Anktiva's capabilities, resulting in false statements about the company's business and prospects.

Univest Securities completed a $2 million registered direct offering for Smart Powerr Corp. (NASDAQ: CREG), with the company selling 4.5 million shares at $0.45 per share. Smart Powerr is a Xi'an-based energy technology company focused on waste energy recycling and energy efficiency solutions, with plans to expand into integrated energy storage solutions.

CompX International Inc. (NYSE American: CIX) announced a regular quarterly dividend of $0.30 per share payable on June 16, 2026. At its annual stockholder meeting on May 20, 2026, shareholders elected eight directors for one-year terms and approved executive compensation on a nonbinding advisory basis.

Old Republic International Corporation announced a regular quarterly dividend of 31.5 cents per share, payable June 15, 2026. The company projects a full-year dividend of $1.26 per share in 2026, representing an 8.6% increase from $1.16 per share in 2025. This marks the 45th consecutive year of dividend increases and the 85th year of uninterrupted dividend payments.

Rosen Law Firm is seeking lead plaintiffs for a securities class action lawsuit against Aldeyra Therapeutics, alleging the company made false and misleading statements about reproxalap clinical trial results. The lawsuit covers purchases between November 3, 2023 and March 16, 2026, with a lead plaintiff deadline of May 29, 2026.